Breast cancer, at least 13 thousand patients should undergo genomic tests

Every year in Italy there are 57 thousand new patients with early breast cancer. Of these, at least 13 thousand should be indicated for a genomic test, currently the reimbursement ceiling is for approximately 10 thousand patients. It was discussed at the European Breast Cancer Conference, now in its 14th edition.